Navigation Links
Study Shows Pine Bark Naturally Reduces Osteoarthritis
Date:4/16/2008

) impact on all inflammatory parameters and have succeeded in providing strong clinical evidence of Pycnogenol(R) efficacy in this field. It is obvious that Pycnogenol(R) will have to be considered as an innovative ingredient of choice for the joint health market," said Victor Ferrari, CEO of Horphag Research, the exclusive worldwide supplier of Pycnogenol(R).

B-Roll Available

Satellite Coordinates

THURSDAY, APRIL 17, 2008/10:00-10:15 AM ET & 2:00-2:15 PM ET

GALAXY 26 TRANSPONDER 1 (C-BAND)

DOWNLINK FREQ: 3720 (V)

About Pycnogenol(R)

Pycnogenol(R) is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and organic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 35 years and has more than 220 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol(R) is available in more than 600 dietary supplements, multi-vitamins and health products worldwide. For more information, visit http://www.pycnogenol.com.

Natural Health Science Inc. (NHS), based in Hoboken, New Jersey, is the North American distributor for Pycnogenol(R) (pic-noj-en-all) brand French maritime pine bark extract on behalf of Horphag Research. Pycnogenol(R) is a registered trademark of Horphag Research Ltd., Guernsey, and its applications are protected by U.S. patents #5,720,956 / #6,372,266 and other international patents. NHS has the exclusive rights to market and sell Pycnogenol(R) in North America and benefits from more than 35 years of scientific research assuring the safety and efficacy of Pycnogenol(R) as a dietary supplement. For more information about Pycnogenol(R) visit our Web site at http://www.pycn
'/>"/>

SOURCE Natural Health Science Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Study suggests too much screen time and not enough physical activity may lead to childhood obesity
2. St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia
3. UAB study shows investigational drug may treat biliary cancers
4. Study shows that high-dose, high-frequency interferon produces no additional benefit
5. Study finds media coverage of breast cancer focuses too little on prevention
6. USC study finds evidence of gender-related differences in development of colon cancer
7. New study in JCSM finds that obesity can predict upper airway obstruction amongst children
8. Study shows increase of hip and knee replacements in the US
9. Study shows decline in work disability due to rheumatoid arthritis
10. Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
11. Study sheds light on deadly lung disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... Decora Preset 60 Minute Countdown Timer , a ... Hardware City.’ The product helps in automatically switching off any ... the related electronic device is automatically turned off after the ... said, “We are glad that this amazing product is now ... Timer Switch in just a few clicks. The product has ...
(Date:5/24/2015)... Michigan (PRWEB) May 24, 2015 ... them to take pressure measurements in patients’ bladder and ... doctor usually orders it if they have reported symptoms ... , Women’s Excellence in Bladder Control is ... unwanted urinary leakage or problems with overall control of ...
(Date:5/24/2015)... Indianapolis, Indiana (PRWEB) May 24, 2015 ... network service provider announces Midwest Telecom of America, Inc. ... , According to Cory Childs, IFN Enterprise Sales ... to service providers. “IFN’s fiber transport provides MTA ... Operations Center to their Tier 1 Internet and voice ...
(Date:5/23/2015)... 23, 2015 On May 13, Nithyananda ... a youngster's yogic power learned through meditation and initiation ... in Bangalore, India. , Yogamaatha, a nine-year-old girl from ... high profile professionals attending the 2015 Business Advocacy Summit ... -- blindfolded. , In a demonstration that lasted ...
(Date:5/23/2015)... Manufacturers are now required to produce water heaters ... Experts in the field agree that the regulation is aimed ... score is what miles per gallon is to your car. ... the minimum HSPF score has been raised to 8.2, technology ... north of 12. Indeed, the regulation was welcomed by environmentalist, ...
Breaking Medicine News(10 mins):Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
... as Executive Vice President, Managing Director, NEW YORK, ... network, announced that Marcy Leger has joined the firm ... LM&P New,York, as a result of the tremendous growth ... President of Euro RSCG Life LM&P New,York and Chicago., ...
... NASA will release a,report on an astronaut and ... media teleconference to discuss the report at 2 ... an independent external committee,conduct a comprehensive review of ... NASA,s Johnson Space Center, Houston, began an internal,assessment ...
... Resources and National Association of Children of Alcoholics Offer ... Free Training Seminar for Clergy on January 30, 2008, ... and drug treatment agency and the National Association of ... others involved,in pastoral care with a free one-day training ...
... history, is determining factor, study finds , , TUESDAY, Jan. ... radiation treatment for fast-moving prostate cancer can save lives, ... have other serious medical problems, a new study shows. ... there definitely is a difference in outcome, depending on ...
... helps patients shed more pounds than dieting and exercise ... New research suggests that gastric lap-band surgery isn,t only for ... who aren,t severely fat. , Still, the surgery is extremely ... people with diabetes who need alternative ways to shed pounds, ...
... 22 STERIS Corporation,(NYSE: STE ) today announced ... dividend in the amount of $0.06 per common share. ... record at the close,of business on February 12, 2008., ... is to provide a healthier today and,safer tomorrow through ...
Cached Medicine News:Health News:Euro RSCG Life LM&P Announces Growth of Leadership Team 2Health News:Hormone Therapy Only Helps Some Older Men With Prostate Cancer 2Health News:Gastric Lap-Band Surgery Can Send Diabetes Into Remission 2Health News:Gastric Lap-Band Surgery Can Send Diabetes Into Remission 3Health News:STERIS Corporation Declares Regular Quarterly Dividend 2Health News:STERIS Corporation Declares Regular Quarterly Dividend 3
(Date:5/22/2015)... May 22, 2015 The North American ... and is estimated to reach $90.7 million by 2019, at ... Browse through the TOC of North America Dental Lasers Market ... help of various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... on this report.   Dental lasers are ...
(Date:5/22/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... the results of the Company,s 72-patient, placebo-controlled Phase ... for the treatment of dry eye patients using ... model.  The exploratory study was completed in late ... by the Company in a press release, identify ...
(Date:5/22/2015)... --  InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the ... announced that its CGuard TM Embolic Prevention System reported ... Piotr Musialek , at the EuroPCR conference on ... PARADIGM, an investigator-initiated P rospective evaluation of ... revascularization I n symptomatic and increased-risk asymptomatic carotid ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Findings Include 80% SVR12 Rate with Nitazoxanide-Based Combination Therapy ... into Mechanism of Action of Nitazoxanide, MILAN, Italy, ... today announced that data from studies of,nitazoxanide in chronic ... presentations made at the 43rd Annual Meeting of the,European ...
... Award of a National Institutes of Health Small, ... Phase 2 Trial, HOUSTON, April 22 Agennix, ... placebo-controlled Phase 2 study,of oral talactoferrin alfa in patients ... talactoferrin in sepsis and is based on both the,mechanism ...
Cached Medicine Technology:Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008 2Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008 3Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008 4Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008 5Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008 6Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008 7Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 2Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 3Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 4Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 5
... are becoming very popular only a few ... the pack. Explore why MediTalk is rapidly ... and practice administrators. An EMR designed by ... doctors see patients quickly and efficiently while ...
Transfer your exams to AltaPoint with our EMR Exam Word Lists. Document systems as normal and annotate exceptions to the systems in the exam. AltaPoint EMR is configured to allow a specialty to cust...
MediNotes e is an EMR design which utilizes a "tab concept for navigation. MediNotes e can display multiple patients, encounter notes, workflow items, patient flow, messages, alerts, and more, all in...
... Software developed a touchscreen EHR and is ... a user can choose to use a ... maintain eye contact while recording encounter results. ... EHR also runs on a pen tablet ...
Medicine Products: